{"id":"iota-carrageenan","safety":{"commonSideEffects":[{"rate":null,"effect":"Nasal irritation"},{"rate":null,"effect":"Sneezing"},{"rate":null,"effect":"Rhinorrhea"}]},"_chembl":{"chemblId":"CHEMBL2108264","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Iota-carrageenan, derived from red seaweed, works through a non-systemic topical mechanism by coating the nasal epithelium and creating a viscous barrier that mechanically traps respiratory viruses (particularly rhinoviruses and other enveloped viruses) before they can attach to and infect host cells. This physical blocking approach does not rely on receptor antagonism or enzymatic inhibition, making it a unique antiviral strategy with a low potential for resistance development.","oneSentence":"Iota-carrageenan is a natural polysaccharide that forms a protective physical barrier on nasal mucosa to trap and prevent viral particles from infecting respiratory epithelial cells.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:50:05.483Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention and treatment of common cold caused by rhinoviruses and other respiratory viruses"}]},"trialDetails":[{"nctId":"NCT07371949","phase":"NA","title":"CHRONO-NUTRITION APPLICATION: THE EFFECT OF FIBER JELLY ON POST PRANDIAL BLOOD GLUCOSE, SATIETY AND WEIGHT LOSS AMONG OVERWEIGHT WOMEN","status":"COMPLETED","sponsor":"Surabaya State University","startDate":"2025-06-30","conditions":"Overweight and Obese Adults","enrollment":28},{"nctId":"NCT06191965","phase":"PHASE2, PHASE3","title":"MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction","status":"RECRUITING","sponsor":"Mclean Hospital","startDate":"2024-06-01","conditions":"Schizophrenia and Related Disorders, Mitochondrial Alteration, Cognitive Impairment","enrollment":100},{"nctId":"NCT06911073","phase":"NA","title":"A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health","status":"RECRUITING","sponsor":"ResBiotic Nutrition, Inc.","startDate":"2025-05-02","conditions":"Obesity and Overweight","enrollment":80},{"nctId":"NCT02568826","phase":"PHASE2","title":"Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain","status":"WITHDRAWN","sponsor":"Indena S.p.A","startDate":"2016-04","conditions":"Low Back Pain","enrollment":""},{"nctId":"NCT06738329","phase":"NA","title":"Investigating the Impact of the Seaweed Derived Food Additive, Carrageenan, on the Human Gut Microbiome","status":"RECRUITING","sponsor":"University of Reading","startDate":"2024-10-01","conditions":"Gut Microbiome, Healthy Donors","enrollment":99},{"nctId":"NCT06552156","phase":"NA","title":"FOod Additives on the Mucosal Barrier","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2022-11-01","conditions":"Healthy","enrollment":60},{"nctId":"NCT06473792","phase":"NA","title":"Effect of Probiotic Toothpaste and Regular Toothpaste on Plaque Levels of Orthodontic Patients","status":"COMPLETED","sponsor":"Kanza Tahir","startDate":"2024-06-04","conditions":"Plaque","enrollment":52},{"nctId":"NCT05049213","phase":"PHASE4","title":"Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2022-06-24","conditions":"Covid19, SARS-CoV 2 Infection","enrollment":7},{"nctId":"NCT05746988","phase":"NA","title":"Carrageenan for the Prevention of Oral HPV Infection","status":"UNKNOWN","sponsor":"McGill University","startDate":"2023-05-26","conditions":"Human Papilloma Virus","enrollment":40},{"nctId":"NCT04590365","phase":"NA","title":"Carrageenan Nasal Spray for COVID-19 Prophylaxis","status":"COMPLETED","sponsor":"Swansea University","startDate":"2020-12-17","conditions":"COVID-19, SARS-CoV 2","enrollment":480},{"nctId":"NCT03408899","phase":"PHASE1","title":"Evaluating the Safety and Pharmacokinetics of PC-1005 Administered Rectally to HIV-1 Seronegative Adults","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-06-19","conditions":"HIV Infections","enrollment":13},{"nctId":"NCT04793984","phase":"NA","title":"Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients","status":"COMPLETED","sponsor":"Marinomed Biotech AG","startDate":"2021-03-08","conditions":"Covid19","enrollment":14},{"nctId":"NCT04681001","phase":"NA","title":"Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers","status":"COMPLETED","sponsor":"Marinomed Biotech AG","startDate":"2020-12-20","conditions":"Respiratory Viral Infection, Common Cold, Severe Acute Respiratory Syndrome (SARS) Pneumonia","enrollment":300},{"nctId":"NCT02354144","phase":"PHASE2, PHASE3","title":"Lubricant Investigation in Men to Inhibit Transmission of HPV Infection","status":"TERMINATED","sponsor":"McGill University","startDate":"2016-02","conditions":"Human Papillomavirus Infection","enrollment":258},{"nctId":"NCT04474561","phase":"NA","title":"Reduced Sulfur Diet in Ulcerative Colitis Patients","status":"COMPLETED","sponsor":"University of Calgary","startDate":"2016-04-20","conditions":"Ulcerative Colitis, Diet Habit","enrollment":42},{"nctId":"NCT04701710","phase":"PHASE1, PHASE2","title":"Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan","status":"COMPLETED","sponsor":"Maria de los Angeles Peral de Bruno","startDate":"2020-10-15","conditions":"Covid19, SARS (Severe Acute Respiratory Syndrome)","enrollment":300},{"nctId":"NCT04532762","phase":"NA","title":"Demonstration of a Decongestant Effect of \"Coldamaris Akut\" Compared to Saline Nasal Spray.","status":"COMPLETED","sponsor":"Marinomed Biotech AG","startDate":"2020-08-04","conditions":"Allergic Rhinitis, Allergic Rhinoconjunctivitis","enrollment":42},{"nctId":"NCT04531358","phase":"NA","title":"Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis","status":"COMPLETED","sponsor":"Marinomed Biotech AG","startDate":"2020-08-04","conditions":"Allergic Rhinitis, Allergic Rhinoconjunctivitis","enrollment":42},{"nctId":"NCT04308980","phase":"PHASE2, PHASE3","title":"Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment","status":"UNKNOWN","sponsor":"Russian Academy of Medical Sciences","startDate":"2020-03-20","conditions":"NAFLD, NASH - Nonalcoholic Steatohepatitis","enrollment":45},{"nctId":"NCT04533906","phase":"NA","title":"Study to Investigate if Sucking a Coldamaris Lozenge Elutes Sufficient Iota-carrageenan to Inactivate Usual Common Cold Viruses","status":"COMPLETED","sponsor":"Marinomed Biotech AG","startDate":"2020-08-04","conditions":"Common Cold, Viral Infection","enrollment":29},{"nctId":"NCT04596566","phase":"NA","title":"Modeling Patient Response to a Therapeutic Diet in Crohn's Disease","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2020-02-20","conditions":"Crohn Disease","enrollment":102},{"nctId":"NCT04425850","phase":"","title":"USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19","status":"COMPLETED","sponsor":"Eurnekian Public Hospital","startDate":"2020-06-01","conditions":"Covid19","enrollment":229},{"nctId":"NCT03755557","phase":"PHASE3","title":"Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray","status":"COMPLETED","sponsor":"Marinomed Biotech AG","startDate":"2018-11-19","conditions":"Allergic Rhinitis, Allergic Conjunctivitis, Hayfever","enrollment":82},{"nctId":"NCT04521322","phase":"PHASE4","title":"Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease","status":"UNKNOWN","sponsor":"Ariel Dogliotti","startDate":"2020-07-24","conditions":"Covid19","enrollment":400},{"nctId":"NCT04240795","phase":"NA","title":"Effect of Lubricity of Food Gels on Satiation and Satiety","status":"COMPLETED","sponsor":"University of Leeds","startDate":"2019-11-01","conditions":"Appetitive Behavior","enrollment":17},{"nctId":"NCT01065571","phase":"NA","title":"Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease Activity","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2010-01","conditions":"Ulcerative Colitis","enrollment":15},{"nctId":"NCT02720393","phase":"NA","title":"Impact of No-carrageenan Diet on Glucose Tolerance in Prediabetes","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2016-02","conditions":"Prediabetes","enrollment":48},{"nctId":"NCT02382419","phase":"PHASE2","title":"Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants","status":"WITHDRAWN","sponsor":"Rutgers, The State University of New Jersey","startDate":"2016-02-24","conditions":"Healthy Subject, Human Papillomavirus Infection","enrollment":""},{"nctId":"NCT02875119","phase":"PHASE1","title":"Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women","status":"COMPLETED","sponsor":"Population Council","startDate":"2017-10-01","conditions":"HIV Infection","enrollment":15},{"nctId":"NCT02629705","phase":"NA","title":"Study of Carrageenan's Effect on Insulin Resistance in Humans","status":"COMPLETED","sponsor":"University Hospital Tuebingen","startDate":"2015-10","conditions":"Diabetes Mellitus, Type 2, Insulin Resistance","enrollment":20},{"nctId":"NCT03118583","phase":"NA","title":"Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers","status":"COMPLETED","sponsor":"Midwest Center for Metabolic and Cardiovascular Research","startDate":"2017-03-15","conditions":"Healthy Volunteers","enrollment":12},{"nctId":"NCT00213044","phase":"PHASE1","title":"A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women","status":"COMPLETED","sponsor":"Population Council","startDate":"2003-03","conditions":"HIV Infections","enrollment":60},{"nctId":"NCT02033109","phase":"PHASE1","title":"Safety, Pharmacokinetics and Acceptability of PC-1005 for Vaginal Use","status":"COMPLETED","sponsor":"Population Council","startDate":"2014-05","conditions":"HIV","enrollment":35},{"nctId":"NCT00213005","phase":"PHASE1","title":"Safety and Acceptability of Carraguard® in HIV Positive Women and Men","status":"COMPLETED","sponsor":"Population Council","startDate":"2002-06","conditions":"HIV Infections","enrollment":60},{"nctId":"NCT00213031","phase":"PHASE2","title":"Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide","status":"COMPLETED","sponsor":"Population Council","startDate":"2000-02","conditions":"HIV Infections, Chlamydia Trachomatis, Neisseria Gonorrhoeae","enrollment":165},{"nctId":"NCT00213018","phase":"PHASE2","title":"Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission","status":"COMPLETED","sponsor":"Population Council","startDate":"1999-10","conditions":"HIV Infections, Chlamydia Trachomatis, Neisseria Gonorrhoeae","enrollment":400},{"nctId":"NCT00213057","phase":"PHASE1","title":"Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand","status":"COMPLETED","sponsor":"Population Council","startDate":"2001-06","conditions":"HIV Infections, Chlamydia Trachomatis, Nesseria Gonorrhea","enrollment":110},{"nctId":"NCT03009799","phase":"PHASE2","title":"Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)","status":"WITHDRAWN","sponsor":"NicOx","startDate":"2017-01","conditions":"Adenoviral Conjunctivitis","enrollment":""},{"nctId":"NCT01647412","phase":"PHASE2","title":"Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2012-03","conditions":"Crohn's Disease","enrollment":""},{"nctId":"NCT01944631","phase":"PHASE4","title":"Iota-Carrageenan Nasal Spray in Common Cold","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2013-09","conditions":"Common Cold","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":460,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["NCX-4240","Placebo"],"phase":"marketed","status":"active","brandName":"Iota-Carrageenan","genericName":"Iota-Carrageenan","companyName":"NicOx","companyId":"nicox","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iota-carrageenan is a natural polysaccharide that forms a protective physical barrier on nasal mucosa to trap and prevent viral particles from infecting respiratory epithelial cells. Used for Prevention and treatment of common cold caused by rhinoviruses and other respiratory viruses.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}